Stock CERE CEREVEL THERAPEUTICS HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Cerevel Therapeutics Holdings, Inc.

Equities

CERE

US15678U1280

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-04-26 EDT 		5-day change 1st Jan Change
42.47 USD +0.95% Intraday chart for Cerevel Therapeutics Holdings, Inc. +0.62% +0.17%
04-18 Sector Update: Health Care Stocks Mixed Pre-Bell Thursday MT
04-18 Cerevel Therapeutics' Potential Parkinson's Treatment Meets Primary Endpoint in Phase 3 Study MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cerevel Therapeutics' Parkinson's disease drug meets main goal in late-stage study
Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson?s Disease
Actinogen Medical Notifies of Errors on M&A Slide in Recent Presentation
Cerevel Therapeutics Holdings Insider Sold Shares Worth $2,057,890, According to a Recent SEC Filing
Cerevel Therapeutics Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Sector Update: Health Care Stocks Gain Late Afternoon
AbbVie Plans $13 Billion Bond Sale to Fund Acquisitions
AbbVie eyes selling at least $13 bln of bonds to fund M&A, Bloomberg reports
AbbVie CEO to Retire; COO Robert Michael Named Successor
BioPharma Credit gets USD50.6 million from Abbvie's ImmunoGen purchase
AbbVie Completes $10.1 Billion Acquisition of ImmunoGen, Lowers Q1 Adjusted EPS Guidance
Omzetdaling Abbvie valt mee
AbbVie profit beats estimates as Humira, Botox sales weather hit from rivals
Neumora Therapeutics Names Kaya Pai Panandiker as Chief Commercial Officer
Cerevel Therapeutics Holdings Insider Sold Shares Worth $424,700, According to a Recent SEC Filing
Cerevel Therapeutics Holdings Insider Sold Shares Worth $331,608, According to a Recent SEC Filing
Cerevel Therapeutics Holdings Insider Sold Shares Worth $571,972, According to a Recent SEC Filing
Cerevel Therapeutics Holdings Insider Sold Shares Worth $259,144, According to a Recent SEC Filing
Cerevel Therapeutics Holdings Insider Sold Shares Worth $292,945, According to a Recent SEC Filing
Cerevel Therapeutics Holdings Insider Sold Shares Worth $326,788, According to a Recent SEC Filing
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CERE Stock
  4. News Cerevel Therapeutics Holdings, Inc.
  5. Other languages